| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 156.99B | 163.64B | 138.28B | 116.44B | 107.02B | 74.49B |
| Gross Profit | 68.85B | 70.90B | 60.53B | 50.33B | 45.14B | 32.67B |
| EBITDA | 19.23B | 20.18B | 17.45B | 14.41B | 12.18B | 8.48B |
| Net Income | 10.95B | 12.09B | 10.59B | 8.86B | 7.33B | 5.78B |
Balance Sheet | ||||||
| Total Assets | 123.67B | 128.62B | 110.91B | 92.68B | 80.70B | 67.34B |
| Cash, Cash Equivalents and Short-Term Investments | 35.37B | 34.31B | 29.48B | 23.55B | 16.91B | 17.92B |
| Total Debt | 16.74B | 18.20B | 11.21B | 8.80B | 5.14B | 2.23B |
| Total Liabilities | 46.98B | 47.88B | 41.48B | 31.77B | 27.60B | 21.61B |
| Stockholders Equity | 76.46B | 80.49B | 69.20B | 60.70B | 52.92B | 45.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | 7.18B | 5.92B | -483.00M | 6.55B |
| Operating Cash Flow | 0.00 | 9.48B | 12.98B | 12.49B | 2.99B | 7.43B |
| Investing Cash Flow | 0.00 | -10.04B | -5.76B | -7.37B | -4.46B | -2.29B |
| Financing Cash Flow | 0.00 | 4.50B | -2.61B | 764.00M | -480.00M | -1.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥54.74B | 24.78 | ― | 3.94% | 2.40% | 15.35% | |
66 Neutral | ¥8.18B | 8.93 | ― | 3.96% | 6.05% | -67.41% | |
64 Neutral | ¥25.87B | 28.87 | ― | 1.85% | 4.87% | -5.52% | |
63 Neutral | ¥1.46T | 27.67 | 5.92% | 1.93% | 1.37% | -38.81% | |
63 Neutral | ¥4.02B | 29.33 | ― | 4.78% | -11.78% | -61.69% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥219.73B | 20.90 | 15.93% | 0.72% | 18.35% | 15.11% |